City
Epaper

2 arthritis drugs show different results in Covid-19 trials

By IANS | Updated: April 28, 2020 22:25 IST

With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.

Open in App
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.

gb/arm

( With inputs from IANS )

Open in App

Related Stories

Other SportsIGPL Finale: Aryan tops table at 9-under as Jeev leads Legends’ impressive show with 7-under

International"Inqilab Moncho very angry with Yunus regime, situation is boiling": Ex Indian Envoy to Bangladesh

NationalAcharya Balakrishna says 'Swadeshi is way of life'; hails PM Modi's commitment

Cricket"Kind of team Virat had, they should've won 3-4 trophies": Harbhajan Singh

CricketNepal has good chance of qualifying for Women's T20 WC: Coach Harshal Jayant

Health Realted Stories

HealthKerala's first skin bank becomes operational in Thiruvananthapuram

Health‘Multai to Multapi’: MP CM announces name change; foundation stone laid for new medical college

HealthGovt reaffirms commitment to integrate surveillance, strengthen labs to combat influenza

HealthExperts call for ramping up science and tech investment in India

HealthHow to Get Rid of Facial Swelling Naturally: Easy Home Hacks for Puffy Face